BIO-Europe Spring Opening Remarks

Inside BIO Industry Analysis

BIO’s own David Thomas, Director of Industry Research, delivered opening remarks at the BIO-Europe Spring conference in Barcelona yesterday. His slides provide a snapshot of the biotech industry’s performance and highlight emerging trends in venture exits: IPOs and M&A.

Takeaways from his talk include breakouts on multiple fronts for the industry:

  • FDA approvals at highs not seen since the 1990s
  • Orphan designation approvals at all-time highs
  • IPOs starting to show signs of life in 2012 and 2013
  • Highest level of structured acquisitions in 2012
  • Highest number of corporate venture rounds on record for 2012
  • Venture returns trending up in 2012

Download the full slide deck here: BES13 – David Thomas Slides

Inside BIO Industry Analysis  |  Email This Post  |  Printer Friendly
Tags: , , , , , , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>